The	O
value	O
of	O
transesophageal	B:C0206054
echocardiography	I:C0206054
for	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
.	O

The	O
value	O
of	O
transesophageal	O
echocardiography	I:C0206054
for	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	B:C0011933
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	B:C0206054
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	B:C0206054
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	B:C0948008
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	B:C0948008
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	B:C0679228
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
diagnostic	O
yield	I:C0011933
of	O
transesophageal	O
echocardiography	I:C0206054
(	O
transesophageal	O
echocardiography	I:C0206054
)	O
in	O
consecutive	O
patients	O
with	O
ischemic	O
stroke	I:C0948008
(	O
ischemic	O
stroke	I:C0948008
)	O
fulfilling	O
the	O
diagnostic	O
criteria	I:C0679228
of	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
)	O
.	O

We	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
ischemic	B:C0948008
stroke	I:C0948008
satisfying	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
criteria	O
who	O
underwent	O
in	O
-	O
hospital	O
TEE	O
examination	I:C0206054
in	O
3	O
tertiary	O
care	I:C0587437
stroke	I:C0587437
centers	I:C0587437
during	O
a	O
12	O
-	O
month	O
period	O
.	O

We	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
ischemic	O
stroke	I:C0948008
satisfying	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
criteria	O
who	O
underwent	O
in	O
-	O
hospital	O
TEE	O
examination	I:C0206054
in	O
3	O
tertiary	O
care	I:C0587437
stroke	I:C0587437
centers	I:C0587437
during	O
a	O
12	O
-	O
month	O
period	O
.	O

We	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
ischemic	O
stroke	I:C0948008
satisfying	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
criteria	O
who	O
underwent	O
in	O
-	O
hospital	B:C0019994
TEE	O
examination	I:C0206054
in	O
3	O
tertiary	O
care	I:C0587437
stroke	I:C0587437
centers	I:C0587437
during	O
a	O
12	O
-	O
month	O
period	O
.	O

We	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
ischemic	O
stroke	I:C0948008
satisfying	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
criteria	O
who	O
underwent	O
in	O
-	O
hospital	O
TEE	B:C0206054
examination	I:C0206054
in	O
3	O
tertiary	O
care	I:C0587437
stroke	I:C0587437
centers	I:C0587437
during	O
a	O
12	O
-	O
month	O
period	O
.	O

We	O
prospectively	O
evaluated	O
consecutive	O
patients	O
with	O
acute	O
ischemic	O
stroke	I:C0948008
satisfying	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
criteria	O
who	O
underwent	O
in	O
-	O
hospital	O
TEE	O
examination	I:C0206054
in	O
3	O
tertiary	B:C0587437
care	I:C0587437
stroke	I:C0587437
centers	I:C0587437
during	O
a	O
12	O
-	O
month	O
period	O
.	O

We	O
also	O
performed	O
a	O
systematic	B:C1955832
review	I:C1955832
and	O
meta-	O
analysis	I:C0920317
estimating	I:C0920317
the	O
cumulative	O
effect	O
of	O
transesophageal	O
echocardiography	I:C0206054
findings	O
on	O
therapeutic	O
management	O
for	O
secondary	O
stroke	I:C1277289
prevention	I:C1277289
among	O
different	O
ischemic	O
stroke	I:C0948008
subgroups	O
.	O

We	O
also	O
performed	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	B:C0920317
analysis	I:C0920317
estimating	I:C0920317
the	O
cumulative	O
effect	O
of	O
transesophageal	O
echocardiography	I:C0206054
findings	O
on	O
therapeutic	O
management	O
for	O
secondary	O
stroke	I:C1277289
prevention	I:C1277289
among	O
different	O
ischemic	O
stroke	I:C0948008
subgroups	O
.	O

We	O
also	O
performed	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	O
analysis	I:C0920317
estimating	I:C0920317
the	O
cumulative	O
effect	O
of	O
transesophageal	B:C0206054
echocardiography	I:C0206054
findings	O
on	O
therapeutic	O
management	O
for	O
secondary	O
stroke	I:C1277289
prevention	I:C1277289
among	O
different	O
ischemic	O
stroke	I:C0948008
subgroups	O
.	O

We	O
also	O
performed	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	O
analysis	I:C0920317
estimating	I:C0920317
the	O
cumulative	O
effect	O
of	O
transesophageal	O
echocardiography	I:C0206054
findings	B:C0243095
on	O
therapeutic	O
management	O
for	O
secondary	O
stroke	I:C1277289
prevention	I:C1277289
among	O
different	O
ischemic	O
stroke	I:C0948008
subgroups	O
.	O

We	O
also	O
performed	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	O
analysis	I:C0920317
estimating	I:C0920317
the	O
cumulative	O
effect	O
of	O
transesophageal	O
echocardiography	I:C0206054
findings	O
on	O
therapeutic	O
management	O
for	O
secondary	B:C1277289
stroke	I:C1277289
prevention	I:C1277289
among	O
different	O
ischemic	O
stroke	I:C0948008
subgroups	O
.	O

We	O
also	O
performed	O
a	O
systematic	O
review	I:C1955832
and	O
meta-	O
analysis	I:C0920317
estimating	I:C0920317
the	O
cumulative	O
effect	O
of	O
transesophageal	O
echocardiography	I:C0206054
findings	O
on	O
therapeutic	O
management	O
for	O
secondary	O
stroke	I:C1277289
prevention	I:C1277289
among	O
different	O
ischemic	B:C0948008
stroke	I:C0948008
subgroups	O
.	O

We	O
identified	O
61	O
patients	O
with	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
who	O
underwent	O
investigation	I:C1261322
with	O
transesophageal	O
echocardiography	I:C0206054
(	O
mean	O
age	O
44	O
±	O
12	O
years	O
,	O
49	O
%	O
men	O
,	O
median	O
NIH	O
Stroke	O
Scale	O
score	O
=	O
5	O
points	O
[	O
interquartile	O
range	O
:	O
3	O
-	O
8	O
]	O
)	O
.	O

We	O
identified	O
61	O
patients	O
with	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
who	O
underwent	B:C1261322
investigation	I:C1261322
with	O
transesophageal	O
echocardiography	I:C0206054
(	O
mean	O
age	O
44	O
±	O
12	O
years	O
,	O
49	O
%	O
men	O
,	O
median	O
NIH	O
Stroke	O
Scale	O
score	O
=	O
5	O
points	O
[	O
interquartile	O
range	O
:	O
3	O
-	O
8	O
]	O
)	O
.	O

We	O
identified	O
61	O
patients	O
with	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
who	O
underwent	O
investigation	I:C1261322
with	O
transesophageal	B:C0206054
echocardiography	I:C0206054
(	O
mean	O
age	O
44	O
±	O
12	O
years	O
,	O
49	O
%	O
men	O
,	O
median	O
NIH	O
Stroke	O
Scale	O
score	O
=	O
5	O
points	O
[	O
interquartile	O
range	O
:	O
3	O
-	O
8	O
]	O
)	O
.	O

We	O
identified	O
61	O
patients	O
with	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
who	O
underwent	O
investigation	I:C1261322
with	O
transesophageal	O
echocardiography	I:C0206054
(	O
mean	O
age	O
44	O
±	O
12	O
years	O
,	O
49	O
%	O
men	B:C0025266
,	O
median	O
NIH	O
Stroke	O
Scale	O
score	O
=	O
5	O
points	O
[	O
interquartile	O
range	O
:	O
3	O
-	O
8	O
]	O
)	O
.	O

transesophageal	B:C0206054
echocardiography	I:C0206054
revealed	O
additional	O
findings	O
in	O
52	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
40	O
%	O
-	O
65	O
%	O
)	O
of	O
the	O
study	O
population	I:C2348561
.	O

transesophageal	O
echocardiography	I:C0206054
revealed	O
additional	O
findings	B:C0243095
in	O
52	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
40	O
%	O
-	O
65	O
%	O
)	O
of	O
the	O
study	O
population	I:C2348561
.	O

transesophageal	O
echocardiography	I:C0206054
revealed	O
additional	O
findings	O
in	O
52	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
40	O
%	O
-	O
65	O
%	O
)	O
of	O
the	O
study	B:C2348561
population	I:C2348561
.	O

transesophageal	B:C0206054
echocardiography	I:C0206054
findings	O
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
,	O
administration	O
of	O
IV	O
antibiotic	I:C0338237
therapy	I:C0338237
,	O
and	O
patent	O
foramen	I:C0189967
ovale	I:C0189967
closure	I:C0189967
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
CI	O
:	O
9%-28	O
%	O
]	O
)	O
patients	O
.	O

transesophageal	O
echocardiography	I:C0206054
findings	B:C0243095
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
,	O
administration	O
of	O
IV	O
antibiotic	I:C0338237
therapy	I:C0338237
,	O
and	O
patent	O
foramen	I:C0189967
ovale	I:C0189967
closure	I:C0189967
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
CI	O
:	O
9%-28	O
%	O
]	O
)	O
patients	O
.	O

transesophageal	O
echocardiography	I:C0206054
findings	O
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	B:C0003281
therapy	I:C0003281
,	O
administration	O
of	O
IV	O
antibiotic	I:C0338237
therapy	I:C0338237
,	O
and	O
patent	O
foramen	I:C0189967
ovale	I:C0189967
closure	I:C0189967
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
CI	O
:	O
9%-28	O
%	O
]	O
)	O
patients	O
.	O

transesophageal	O
echocardiography	I:C0206054
findings	O
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
,	O
administration	B:C1533734
of	O
IV	O
antibiotic	I:C0338237
therapy	I:C0338237
,	O
and	O
patent	O
foramen	I:C0189967
ovale	I:C0189967
closure	I:C0189967
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
CI	O
:	O
9%-28	O
%	O
]	O
)	O
patients	O
.	O

transesophageal	O
echocardiography	I:C0206054
findings	O
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
,	O
administration	O
of	O
IV	B:C0338237
antibiotic	I:C0338237
therapy	I:C0338237
,	O
and	O
patent	O
foramen	I:C0189967
ovale	I:C0189967
closure	I:C0189967
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
CI	O
:	O
9%-28	O
%	O
]	O
)	O
patients	O
.	O

transesophageal	O
echocardiography	I:C0206054
findings	O
changed	O
management	O
(	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
,	O
administration	O
of	O
IV	O
antibiotic	I:C0338237
therapy	I:C0338237
,	O
and	O
patent	B:C0189967
foramen	I:C0189967
ovale	I:C0189967
closure	I:C0189967
)	O
in	O
10	O
(	O
16	O
%	O
[	O
95	O
%	O
CI	O
:	O
9%-28	O
%	O
]	O
)	O
patients	O
.	O

The	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	B:C0003281
therapy	I:C0003281
attributed	O
to	O
abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	O
among	O
3,562	O
acute	O
ischemic	O
stroke	I:C0948008
patients	O
included	O
in	O
the	O
meta-analysis	O
(	O
12	O
studies	O
)	O
was	O
8.7	O
%	O
(	O
95	O
%	O
CI	O
:	O
7.3%	O
-	O
10.4	O
%	O
)	O
.	O

The	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	O
therapy	I:C0003281
attributed	O
to	O
abnormal	B:C0205161
transesophageal	O
echocardiography	I:C0206054
findings	O
among	O
3,562	O
acute	O
ischemic	O
stroke	I:C0948008
patients	O
included	O
in	O
the	O
meta-analysis	O
(	O
12	O
studies	O
)	O
was	O
8.7	O
%	O
(	O
95	O
%	O
CI	O
:	O
7.3%	O
-	O
10.4	O
%	O
)	O
.	O

The	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	O
therapy	I:C0003281
attributed	O
to	O
abnormal	O
transesophageal	B:C0206054
echocardiography	I:C0206054
findings	O
among	O
3,562	O
acute	O
ischemic	O
stroke	I:C0948008
patients	O
included	O
in	O
the	O
meta-analysis	O
(	O
12	O
studies	O
)	O
was	O
8.7	O
%	O
(	O
95	O
%	O
CI	O
:	O
7.3%	O
-	O
10.4	O
%	O
)	O
.	O

The	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	O
therapy	I:C0003281
attributed	O
to	O
abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	B:C0243095
among	O
3,562	O
acute	O
ischemic	O
stroke	I:C0948008
patients	O
included	O
in	O
the	O
meta-analysis	O
(	O
12	O
studies	O
)	O
was	O
8.7	O
%	O
(	O
95	O
%	O
CI	O
:	O
7.3%	O
-	O
10.4	O
%	O
)	O
.	O

The	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	O
therapy	I:C0003281
attributed	O
to	O
abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	O
among	O
3,562	O
acute	O
ischemic	B:C0948008
stroke	I:C0948008
patients	O
included	O
in	O
the	O
meta-analysis	O
(	O
12	O
studies	O
)	O
was	O
8.7	O
%	O
(	O
95	O
%	O
CI	O
:	O
7.3%	O
-	O
10.4	O
%	O
)	O
.	O

The	O
pooled	O
rate	O
of	O
reported	O
anticoagulation	O
therapy	I:C0003281
attributed	O
to	O
abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	O
among	O
3,562	O
acute	O
ischemic	O
stroke	I:C0948008
patients	O
included	O
in	O
the	O
meta-analysis	B:C0920317
(	O
12	O
studies	O
)	O
was	O
8.7	O
%	O
(	O
95	O
%	O
CI	O
:	O
7.3%	O
-	O
10.4	O
%	O
)	O
.	O

In	O
subgroup	B:C0936012
analysis	I:C0936012
,	O
the	O
rates	O
of	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
on	O
the	O
basis	O
of	O
transesophageal	O
echocardiography	I:C0206054
investigation	O
did	O
not	O
differ	O
(	O
p	O
=	O
0.315	O
)	O
among	O
patients	O
with	O
cryptogenic	O
stroke	O
(	O
6.9	O
%	O
[	O
95	O
%	O
CI	O
:	O
4.9	O
%	O
-	O
9.6	O
%	O
]	O
)	O
,	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
8.1	O
%	O
[	O
95	O
%	O
CI	O
:	O
3.4%-	O
18.1	O
%	O
]	O
)	O
,	O
and	O
ischemic	O
stroke	I:C0948008
(	O
9.4	O
%	O
[	O
95	O
%	O
CI	O
:	O
7.5%-	O
11.8	O
%	O
]	O
)	O
.	O

In	O
subgroup	O
analysis	I:C0936012
,	O
the	O
rates	O
of	O
initiation	O
of	O
anticoagulation	B:C0003281
therapy	I:C0003281
on	O
the	O
basis	O
of	O
transesophageal	O
echocardiography	I:C0206054
investigation	O
did	O
not	O
differ	O
(	O
p	O
=	O
0.315	O
)	O
among	O
patients	O
with	O
cryptogenic	O
stroke	O
(	O
6.9	O
%	O
[	O
95	O
%	O
CI	O
:	O
4.9	O
%	O
-	O
9.6	O
%	O
]	O
)	O
,	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
8.1	O
%	O
[	O
95	O
%	O
CI	O
:	O
3.4%-	O
18.1	O
%	O
]	O
)	O
,	O
and	O
ischemic	O
stroke	I:C0948008
(	O
9.4	O
%	O
[	O
95	O
%	O
CI	O
:	O
7.5%-	O
11.8	O
%	O
]	O
)	O
.	O

In	O
subgroup	O
analysis	I:C0936012
,	O
the	O
rates	O
of	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
on	O
the	O
basis	O
of	O
transesophageal	B:C0206054
echocardiography	I:C0206054
investigation	O
did	O
not	O
differ	O
(	O
p	O
=	O
0.315	O
)	O
among	O
patients	O
with	O
cryptogenic	O
stroke	O
(	O
6.9	O
%	O
[	O
95	O
%	O
CI	O
:	O
4.9	O
%	O
-	O
9.6	O
%	O
]	O
)	O
,	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
8.1	O
%	O
[	O
95	O
%	O
CI	O
:	O
3.4%-	O
18.1	O
%	O
]	O
)	O
,	O
and	O
ischemic	O
stroke	I:C0948008
(	O
9.4	O
%	O
[	O
95	O
%	O
CI	O
:	O
7.5%-	O
11.8	O
%	O
]	O
)	O
.	O

In	O
subgroup	O
analysis	I:C0936012
,	O
the	O
rates	O
of	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
on	O
the	O
basis	O
of	O
transesophageal	O
echocardiography	I:C0206054
investigation	O
did	O
not	O
differ	O
(	O
p	O
=	O
0.315	O
)	O
among	O
patients	O
with	O
cryptogenic	O
stroke	O
(	O
6.9	O
%	O
[	O
95	O
%	O
CI	O
:	O
4.9	O
%	O
-	O
9.6	O
%	O
]	O
)	O
,	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
8.1	O
%	O
[	O
95	O
%	O
CI	O
:	O
3.4%-	O
18.1	O
%	O
]	O
)	O
,	O
and	O
ischemic	O
stroke	I:C0948008
(	O
9.4	O
%	O
[	O
95	O
%	O
CI	O
:	O
7.5%-	O
11.8	O
%	O
]	O
)	O
.	O

In	O
subgroup	O
analysis	I:C0936012
,	O
the	O
rates	O
of	O
initiation	O
of	O
anticoagulation	O
therapy	I:C0003281
on	O
the	O
basis	O
of	O
transesophageal	O
echocardiography	I:C0206054
investigation	O
did	O
not	O
differ	O
(	O
p	O
=	O
0.315	O
)	O
among	O
patients	O
with	O
cryptogenic	O
stroke	O
(	O
6.9	O
%	O
[	O
95	O
%	O
CI	O
:	O
4.9	O
%	O
-	O
9.6	O
%	O
]	O
)	O
,	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
(	O
8.1	O
%	O
[	O
95	O
%	O
CI	O
:	O
3.4%-	O
18.1	O
%	O
]	O
)	O
,	O
and	O
ischemic	B:C0948008
stroke	I:C0948008
(	O
9.4	O
%	O
[	O
95	O
%	O
CI	O
:	O
7.5%-	O
11.8	O
%	O
]	O
)	O
.	O

Abnormal	O
transesophageal	B:C0206054
echocardiography	I:C0206054
findings	O
may	O
decisively	O
affect	O
the	O
selection	O
of	O
appropriate	O
therapeutic	O
strategy	I:C0087111
in	O
approximately	O
1	O
of	O
7	O
patients	O
with	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
.	O

Abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	B:C0243095
may	O
decisively	O
affect	O
the	O
selection	O
of	O
appropriate	O
therapeutic	O
strategy	I:C0087111
in	O
approximately	O
1	O
of	O
7	O
patients	O
with	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
.	O

Abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	O
may	O
decisively	O
affect	O
the	O
selection	O
of	O
appropriate	O
therapeutic	B:C0087111
strategy	I:C0087111
in	O
approximately	O
1	O
of	O
7	O
patients	O
with	O
embolic	O
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
.	O

Abnormal	O
transesophageal	O
echocardiography	I:C0206054
findings	O
may	O
decisively	O
affect	O
the	O
selection	O
of	O
appropriate	O
therapeutic	O
strategy	I:C0087111
in	O
approximately	O
1	O
of	O
7	O
patients	O
with	O
embolic	B:C3888970
strokes	I:C3888970
of	I:C3888970
undetermined	I:C3888970
source	I:C3888970
.	O

